[go: up one dir, main page]

PT761218E - Processo para preparar comprimidos revestidos com polimeros compreendendo amoxicilina e clavunalato - Google Patents

Processo para preparar comprimidos revestidos com polimeros compreendendo amoxicilina e clavunalato Download PDF

Info

Publication number
PT761218E
PT761218E PT96202848T PT96202848T PT761218E PT 761218 E PT761218 E PT 761218E PT 96202848 T PT96202848 T PT 96202848T PT 96202848 T PT96202848 T PT 96202848T PT 761218 E PT761218 E PT 761218E
Authority
PT
Portugal
Prior art keywords
tablet
weight
film coating
clavulanate
amoxycillin
Prior art date
Application number
PT96202848T
Other languages
English (en)
Portuguese (pt)
Inventor
Nigel Philip Davidson
Creighton Pierce Conley
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT761218(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PT761218E publication Critical patent/PT761218E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT96202848T 1994-04-23 1995-04-19 Processo para preparar comprimidos revestidos com polimeros compreendendo amoxicilina e clavunalato PT761218E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408117A GB9408117D0 (en) 1994-04-23 1994-04-23 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
PT761218E true PT761218E (pt) 2001-03-30

Family

ID=10754044

Family Applications (4)

Application Number Title Priority Date Filing Date
PT00204182T PT1093813E (pt) 1994-04-23 1995-04-19 Processo para preparacao de comprimidos revestidos de polimero compreendendo amoxicilina e clavulanato revestidos com uma pelicula polimerica aquosa
PT96202848T PT761218E (pt) 1994-04-23 1995-04-19 Processo para preparar comprimidos revestidos com polimeros compreendendo amoxicilina e clavunalato
PT95917937T PT758235E (pt) 1994-04-23 1995-04-19 Comprimido revestido com polimero compreendendo amoxicilina e clavulanato
PT99200891T PT978276E (pt) 1994-04-23 1995-04-19 Comprimidos com revestimento de polimero que compreendem amoxicilina e clavulanato

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT00204182T PT1093813E (pt) 1994-04-23 1995-04-19 Processo para preparacao de comprimidos revestidos de polimero compreendendo amoxicilina e clavulanato revestidos com uma pelicula polimerica aquosa

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT95917937T PT758235E (pt) 1994-04-23 1995-04-19 Comprimido revestido com polimero compreendendo amoxicilina e clavulanato
PT99200891T PT978276E (pt) 1994-04-23 1995-04-19 Comprimidos com revestimento de polimero que compreendem amoxicilina e clavulanato

Country Status (35)

Country Link
US (1) US6051255A (fr)
EP (5) EP1243267A3 (fr)
JP (1) JP3622975B2 (fr)
CN (1) CN1134258C (fr)
AP (2) AP564A (fr)
AT (6) ATE223706T1 (fr)
AU (1) AU684949B2 (fr)
BG (1) BG62842B1 (fr)
BR (1) BR9507502A (fr)
CA (1) CA2188496A1 (fr)
CZ (2) CZ294168B6 (fr)
DE (5) DE69519093T2 (fr)
DK (4) DK0761218T3 (fr)
DZ (1) DZ1876A1 (fr)
ES (4) ES2182754T3 (fr)
FI (1) FI964249A7 (fr)
GB (1) GB9408117D0 (fr)
GR (2) GR3035031T3 (fr)
HK (1) HK1050992A1 (fr)
HU (1) HU228399B1 (fr)
IL (1) IL113433A (fr)
MA (1) MA23528A1 (fr)
MY (1) MY115351A (fr)
NO (1) NO310703B1 (fr)
NZ (1) NZ285080A (fr)
OA (1) OA10377A (fr)
PL (1) PL316966A1 (fr)
PT (4) PT1093813E (fr)
RO (1) RO116997B1 (fr)
RU (1) RU2152213C1 (fr)
SA (1) SA95160343B1 (fr)
SI (1) SI0758235T1 (fr)
SK (1) SK282594B6 (fr)
WO (1) WO1995028927A1 (fr)
ZA (1) ZA953236B (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
ATE208618T1 (de) 1995-09-07 2001-11-15 Smithkline Beecham Corp Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
WO1998034598A2 (fr) * 1997-02-07 1998-08-13 Gist-Brocades B.V. Formulations homogenes sous forme de granules destinees a la technologie d'aspiration des doses
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
SK110299A3 (en) * 1997-02-14 2000-08-14 Smithkline Beecham Lab Pharmaceutical formulations comprising amoxocyllin and clavulanate, preparation method and use thereof
TR200000529T2 (tr) * 1997-08-29 2000-08-21 Dsm N.V. İçinde eksipiyan olmayan granüller
EP1032425A1 (fr) 1997-10-31 2000-09-06 Monsanto Company Enrobage de comprimes a l'aide de gomme gellane
WO2000041478A2 (fr) 1999-04-01 2000-07-20 Dsm N.V. Agglomerats obtenus par cristallisation
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
ES2202004T3 (es) * 1999-04-13 2004-04-01 Beecham Pharmaceuticals (Pte) Limited Novedoso procedimiento de tratamiento usando un fuerte regimen de dosificacion de amoxicilina y clavulanato potasico.
US20040038948A1 (en) * 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
WO2002002081A1 (fr) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Composition semi-solide a fusion rapide, leurs procedes de production et leurs procedes d'utilisation
WO2002030392A2 (fr) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
ES2373873T3 (es) * 2001-04-10 2012-02-09 Sun Pharma Advanced Research Company Limited Composición de liberación por impulso temporizado.
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
AU2003210925A1 (en) * 2002-02-07 2003-09-02 Rutgers, The State University Antibiotic polymers
DE60306120T2 (de) * 2002-02-14 2006-11-09 Glaxo Group Ltd., Greenford Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
GB0203528D0 (en) * 2002-02-14 2002-04-03 Glaxo Group Ltd Process and composition
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
CA2406592C (fr) * 2002-10-04 2003-09-30 Duchesnay Inc. Mode de preparation de formes posologiques pharmaceutiques contenant de multiples principes actifs
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
CA2533178C (fr) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Produit antibiotique, son utilisation et sa formulation
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
US8425936B2 (en) * 2003-07-21 2013-04-23 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2007502296A (ja) * 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
CA2535398C (fr) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotique, utilisation et formulation associees
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
WO2005027877A1 (fr) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotique, son utilisation et sa formulation
WO2005062898A2 (fr) * 2003-12-24 2005-07-14 Advancis Pharmaceutical Corporation Absorption amelioree de formes de dosage a liberation modifiee
EP1725555B1 (fr) 2004-03-08 2010-10-06 Prosidion Ltd. Hydrazides d'acide pyrrolopyridine-2-carboxylique utilises comme inhibiteurs de la glycogene phosphorylase
WO2006014427A1 (fr) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Comprimé pour distribution par impulsion
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
WO2006123765A1 (fr) 2005-05-20 2006-11-23 Daiichi Sankyo Company, Limited Preparation recouverte d’un film
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
CN102596184B (zh) * 2009-09-18 2015-03-11 赛诺菲 稳定性提高的(z)-2-氰基-3-羟基-丁-2-烯酸-(4’-三氟甲基苯基)-酰胺片剂制剂
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) * 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (fr) * 1981-12-02 1985-09-25 Beecham Group Plc Préparation pharmaceutique contenant des antibiotiques béta-lactame
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ES2202004T3 (es) * 1999-04-13 2004-04-01 Beecham Pharmaceuticals (Pte) Limited Novedoso procedimiento de tratamiento usando un fuerte regimen de dosificacion de amoxicilina y clavulanato potasico.
WO2002030392A2 (fr) * 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation

Also Published As

Publication number Publication date
EP1093813A3 (fr) 2001-05-30
EP0978276B1 (fr) 2002-09-11
GR3035031T3 (en) 2001-03-30
DZ1876A1 (fr) 2002-02-17
ZA953236B (en) 1995-12-27
PT978276E (pt) 2003-01-31
CZ294168B6 (cs) 2004-10-13
ATE223706T1 (de) 2002-09-15
OA10377A (en) 2001-11-21
EP0978276A3 (fr) 2000-04-12
WO1995028927A1 (fr) 1995-11-02
AT5349U1 (de) 2002-06-25
HK1009936A1 (en) 1999-06-11
RO116997B1 (ro) 2001-09-28
HU9602922D0 (en) 1996-12-30
HK1021860A1 (en) 2000-07-07
ES2182754T3 (es) 2003-03-16
EP1093813A2 (fr) 2001-04-25
PT1093813E (pt) 2003-02-28
HK1050992A1 (en) 2003-07-18
FI964249L (fi) 1996-10-22
AP9500733A0 (en) 1995-04-30
IL113433A (en) 2003-06-24
RU2152213C1 (ru) 2000-07-10
ES2161288T3 (es) 2001-12-01
CN1134258C (zh) 2004-01-14
EP0758235A1 (fr) 1997-02-19
SI0758235T1 (en) 2001-10-31
AU2406895A (en) 1995-11-16
DE69528204D1 (de) 2002-10-17
DE69521799D1 (de) 2001-08-23
CZ11376U1 (cs) 2001-07-12
MA23528A1 (fr) 1995-12-31
CZ309096A3 (en) 1997-04-16
FI964249A0 (fi) 1996-10-22
NO964488L (no) 1996-12-17
AU684949B2 (en) 1998-01-08
AT5350U1 (de) 2002-06-25
DE69519093T2 (de) 2001-07-19
NO964488D0 (no) 1996-10-22
DE69528204T2 (de) 2003-08-07
EP0761218B1 (fr) 2000-10-11
GB9408117D0 (en) 1994-06-15
HUT76335A (en) 1997-08-28
US6051255A (en) 2000-04-18
EP0758235B1 (fr) 2001-07-18
DK0978276T3 (da) 2003-01-20
HK1027024A1 (en) 2001-01-05
MY115351A (en) 2003-05-31
HK1036404A1 (en) 2002-01-04
DK0761218T3 (da) 2000-12-18
EP0761218A1 (fr) 1997-03-12
DE69519093D1 (de) 2000-11-16
AP564A (en) 1996-11-21
DK1093813T3 (da) 2003-02-17
DE69528608D1 (de) 2002-11-21
SA95160343B1 (ar) 2005-05-04
SK282594B6 (sk) 2002-10-08
AP9600868A0 (en) 1996-10-31
FI964249A7 (fi) 1996-10-22
ATE196845T1 (de) 2000-10-15
EP1243267A2 (fr) 2002-09-25
NZ285080A (en) 1998-05-27
ATE226074T1 (de) 2002-11-15
PT758235E (pt) 2001-10-31
DE29522153U1 (de) 2000-04-06
PL316966A1 (en) 1997-03-03
CN1149829A (zh) 1997-05-14
ES2152485T3 (es) 2001-02-01
NO310703B1 (no) 2001-08-20
SK135496A3 (en) 1997-05-07
BG62842B1 (bg) 2000-09-29
EP0978276A2 (fr) 2000-02-09
ES2180251T3 (es) 2003-02-01
ATE203161T1 (de) 2001-08-15
CA2188496A1 (fr) 1995-11-02
IL113433A0 (en) 1995-07-31
BG100933A (en) 1997-07-31
EP1093813B1 (fr) 2002-10-16
DK0758235T3 (da) 2001-10-29
JP3622975B2 (ja) 2005-02-23
JPH09512027A (ja) 1997-12-02
EP1243267A3 (fr) 2002-10-30
GR3036844T3 (en) 2002-01-31
DE69521799T2 (de) 2002-06-13
DE69528608T2 (de) 2003-06-26
HU228399B1 (en) 2013-03-28
BR9507502A (pt) 1997-09-02

Similar Documents

Publication Publication Date Title
PT761218E (pt) Processo para preparar comprimidos revestidos com polimeros compreendendo amoxicilina e clavunalato
JP2002541187A (ja) 新規治療法
CZ225596A3 (en) Film-coated tablets of paracetamol and domperidon
HUP0400127A2 (hu) Paracetamolt tartalmazó lenyelhető tabletta
WO2008029351A2 (fr) Formulation à libération modifiée comprenant de l'amoxicilline et un clavulanate
WO2013057569A2 (fr) Composition pharmaceutique à libération prolongée contenant de l'amoxicilline et de l'acide clavulanique
MXPA96005055A (en) Polymer revestible tablet that comprises amoxicillin and clavulan
HK1021860B (en) Process for preparing polymer coated tablet comprising amoxycllin and clavunalate, coated with an aqueous polymeric filmcoating
HK1036404B (en) Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating
HK1009936B (en) Polymer coated tablet comprising amoxycillin and clavulanate
HK1027024B (en) Polymer coated tablet comprising amoxycillin and clavunalate
WO2013001541A1 (fr) Forme galénique de type comprimé bicouches optimisée présentant un taux élevé de biodisponibilité pour deux antibiotiques actifs : le céfuroxime et l'acide clavulanique